BMJ10h
MIND AND MOVEMENT: THE NEUROPSYCHIATRY OF MOVEMENT DISORDERS
Correspondence to: Dr Graham G Lennox, Department of Neurology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; email: bl224{at}cam.ac.uk The irritating historical division between neurology and ...
BMJ1d
Efficacy of pulse intravenous methylprednisolone in epileptic encephalopathy: a randomised controlled trial
Correspondence to Dr Sanjib Sinha, Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India; sanjib_sinha2004{at}yahoo.co.in Background High-level ...
BMJ2d
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease
Background Synaptosomal-associated protein 25 (SNAP-25) in cerebrospinal fluid (CSF) is an emerging synaptic biomarker for the early diagnosis of Alzheimer’s disease (AD). However, comprehensive ...
BMJ3d
The notion of “warning leaks” in subarachnoid haemorrhage: are such patients in fact admitted with a rebleed?
a University Department of Neurology, Utrecht, The Netherlands, b Julius Center for Patient Oriented Research, Utrecht, The Netherlands Dr F H H Linn, University Department of Neurology, ...
BMJ6d
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging
Dr R Barber, Institute for the Health of the Elderly, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE, U.K. Tel +(0)191 256 3274 ext. 22986; fax +(0)191 219 5048; email ...
BMJ5d
Neurology and the bone marrow
aInstitute of Clinical Neurosciences, bKanematsu Laboratories, Royal Prince Alfred Hospital, NSW, 2006 Australia Professor JD Pollard, Institute of Clinical Neurosciences, University of Sydney, ...
BMJ1d
Regional changes in hippocampal T2 relaxation and volume: a quantitative magnetic resonance imaging study of hippocampal sclerosis
Professor JS Duncan, National Society for Epilepsy, National Hospital for Neurology and Neurosurgery, Chalfont St Peter, Gerrards Cross, Bucks SL9 0RJ, UK. Telephone 0044 (0) 1494 601300; fax 0044 (0) ...
BMJ13d
The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease
OBJECTIVE To test the feasibility and validity of the EQ-5D (a widely used generic (disease non-specific) quality of life (QoL) instrument which allows comparisons between different patient groups and ...
BMJ3d
Performance validity test failure in clinical populations—a systematic review
Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH8 9YL, UK; laura.mcwhirter{at}ed.ac.uk Performance validity tests (PVTs) are widely used ...
BMJ8d
Large scale brain models of epilepsy: dynamics meets connectomics
The brain is in a constant state of dynamic change, for example switching between cognitive and behavioural tasks, and between wakefulness and sleep. The brains of people with epilepsy have additional ...
BMJ7d
Brain penetration effects of microelectrodes and DBS leads in STN or GPi
Department of Neurology, University of Florida College of Medicine/Shands Hospital, Movement Disorders Center, McKnight Brain Institute, Gainesville, Florida, USA Objective: To determine how ...
BMJ4d
Ischaemic stroke in young adults: predictors of outcome and recurrence
Correspondence to: Dr Ralf W Baumgartner Department of Neurology, University Hospital of Zürich, Frauenklinikstrasse 26, CH-8091 Zürich, Switzerland; ralf.baumgartnernos.usz.ch Background: There is ...